Nichols Asset Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$523K Hold
1,845
1.03% 32
2016
Q3
$578K Hold
1,845
1.08% 26
2016
Q2
$446K Hold
1,845
0.91% 38
2016
Q1
$480K Hold
1,845
0.11% 77
2015
Q4
$565K Hold
1,845
0.12% 75
2015
Q3
$538K Hold
1,845
0.12% 80
2015
Q2
$745K Hold
1,845
0.13% 70
2015
Q1
$779K Hold
1,845
0.14% 72
2014
Q4
$626K Hold
1,845
0.12% 79
2014
Q3
$610K Hold
1,845
0.13% 78
2014
Q2
$581K Sell
1,845
-470
-20% -$141K 0.12% 80
2014
Q1
$708K Buy
2,315
+50
+2% +$15.9K 0.16% 77
2013
Q4
$633K Hold
2,265
0.13% 80
2013
Q3
$545K Buy
2,265
+500
+28% +$112K 0.15% 83
2013
Q2
$380K Buy
+1,765
New +$377K 0.12% 94

Other funds holding BIIB

Nichols Asset Management's BIIB Position: Q4 2016 in Review

Nichols Asset Management held its Biogen (BIIB) position steady in Q4 2016 at 1,845 shares worth $523K. The position accounts for 1.03% of the portfolio, ranked #32.

Nichols Asset Management first reported a position in BIIB in Q2 2013 and has held it in 15 quarters since. The position peaked at $779K in Q1 2015. 1,025 funds tracked by Wall St. Rank hold BIIB as of Q4 2016.

  • Nichols Asset Management held 1,845 shares of Biogen worth $523K as of Q4 2016.
  • Nichols Asset Management left its Biogen share count unchanged in Q4 2016.
  • Biogen made up 1.03% of Nichols Asset Management's portfolio in Q4 2016, its #32 holding.
  • Nichols Asset Management first reported a position in Biogen in Q2 2013 and has held it in 15 quarters since.
  • Nichols Asset Management's Biogen position peaked at $779K in Q1 2015.
  • 1,025 funds tracked by Wall St. Rank held Biogen as of Q4 2016.

Based on Nichols Asset Management's 13F filing for Q4 2016, filed 10 Feb 2017.